April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
The Impact of MicroRNAs on Nr2e3 Associated Retinal Disease
Author Affiliations & Notes
  • Austin S. Jelcick
    Genetics Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska
  • James Reinecke
    Genetics Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska
  • Yang Yuan
    Genetics Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska
  • Neena B. Haider
    Genetics, Cell Biology, Anatomy, Univ of Nebraska Medical Ctr, Omaha, Nebraska
  • Footnotes
    Commercial Relationships  Austin S. Jelcick, None; James Reinecke, None; Yang Yuan, None; Neena B. Haider, None
  • Footnotes
    Support  Grant P20-RRO18788-03, NIH Grant EY017653, NIH Hope for Vision Award
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5416. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Austin S. Jelcick, James Reinecke, Yang Yuan, Neena B. Haider; The Impact of MicroRNAs on Nr2e3 Associated Retinal Disease. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5416.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : The purpose of this study is to evaluate the impact of microRNAs (miRNA) on Nr2e3 associated retinal disease. Nr2e3 is a critical for photoreceptor development and function. Lack of human Nr2e3 is associated with enhanced S-cone syndrome and retinitis pigmentosa, resulting in excessive production of blue opsin expressing cone cells and progressive retinal degeneration. The rd7 mouse model, lacking a functional Nr2e3 gene, exhibits a superfluous blue cone population and slow progressive retinal degeneration. Our current study examines the expression levels of potential target genes of miRNAs and their involvement in key differentially expressed gene networks.

Methods: : MiRNAs were isolated at E18, P6, P14, and P30 in C57BL6/J and rd7 mice for microarray analysis. Expression levels of potential target genes of expressed miRNAs were measured by quantitative real-time PCR. Pathways analysis (Ingenuity Pathway Analysis, Ariadne Pathway Studio) of potential target genes probed relationships between these and pathways previously found to be differentially expressed between strains and temporally. Additionally, we performed immunohistochemical and western blot analysis to determine the impact of miRNA expression on protein expression and localization.

Results: : We identified 15 highly significant, differentially expressed miRNAs. MicroRNA expression levels varied temporally between developmental time points, and included variations in the sensory neural miRNA cluster of 182/183/96. Potential targets also varied temporally in expression with some targets associated with retinal disease.

Conclusions: : We observe temporal variations in miRNA expression and in their potential targets. These targets vary in function, including transcription, apoptosis, metabolism, and the cell cycle. This provides evidence for miRNA expression altering target gene expression, and subsequently affecting phenotypic outcome. These studies will provide additional insight into the genetic and subsequent phenotypic consequences arising as a result of miRNA expression variation.

Keywords: genetics • gene/expression • retinal development 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.